Stock Movers: Home Depot Earnings, Pfizer-3SBio Deal, UnitedHealth Rebound, Coinbase Investigation

Home Depot's Financial Performance

• 🏠 Home Depot's shares experienced volatility despite reporting earnings that missed estimates, with comparable sales declining by 0.3% in the quarter ending May 4.
• 📉 The company's CFO cited weakening consumer sentiment and economic turbulence, leading consumers to postpone larger purchases due to interest rate concerns.
• 📈 Despite a slowdown in larger projects, smaller projects are providing a significant boost, and the company maintained its full-year guidance, which includes the impact of tariffs.

Pfizer and 3SBio Collaboration

• 🚀 3SBio shares surged in Hong Kong following a significant licensing deal with Pfizer for a cancer treatment candidate.
• 💰 The agreement could be worth up to $6.05 billion, with Pfizer paying $1.25 billion upfront for global rights to the experimental drug, setting a new record for China licensing deals.
• 🌐 This collaboration highlights a growing trend of pharmaceutical companies, including Pfizer, seeking to refill their pipelines with drugs originating from China.

UnitedHealth Group's Stock Recovery

• 🏥 UnitedHealth Group shares are showing a rebound, climbing significantly after a notable drop last week.
• 🤝 The recovery was bolstered by SEC filings revealing that the newly appointed CEO and CFO purchased approximately $30 million worth of the company's stock.

Coinbase and Regulatory Scrutiny

• 📈 Coinbase shares are trading higher, influenced by the broader Bitcoin market and developments in stablecoin legislation.
• ⚖️ The US Senate is moving forward with a debate and potential vote on stablecoin legislation, though it faces opposition regarding safeguards against financial system risks and exploitation by criminals.
• 🔍 Reports indicate the Justice Department may be opening an investigation into a recent data breach at Coinbase, which allegedly involved bribing employees in India for client information, though Coinbase states they are not under DOJ investigation.